Is there a difference in the number of interstitial cells, neurons, presence of fibrosis and inflammation in ureteropelvic junction tissues of patients with ureteropelvic junction obstruction with and without crossing vessels?

OBJECTIVE We compared the number of interstitial cells (ICs), nerves, presence of fibrosis and inflammation at the level of full-thickness human ureteropelvic junction (UPJ) tissues obtained from normal subjects, and patients with UPJ obstruction with and without crossing vessels. MATERIAL AND METHODS Normal UPJ tissues (n=12) histopathologically confirmed to be without tumor involvement were obtained from subjects who underwent radical nephrectomy for kidney mass. Additional UPJ tissues were obtained from patients who underwent pyeloplasty due to UPJ obstruction. Crossing vessel was identified in 17 patients. In 57 patients, no crossing-vessel was noted. ICs were stained immunohistochemically with anti-human CD117 (c-kit) antibody. Neural tissue was stained with S-100. The numbers of ICs and neurons were compared between the groups: controls with normal UPJ (Group I), Ureteropelvic junction obtruction (UPJO) with crossing vessel (Group II) and UPJ obstruction without crossing vessel (Group III). Groups were also compared in terms of the presence of fibrosis and inflammation. RESULTS The mean age of total population included in the study was 30.5±18.5 years. No significant differences were detected between the three groups regarding mean and median numbers of ICs at the level of UPJ (lamina propria and muscle layer) and mean and median numbers of neurons at the level of lamina propria (p>0.05). Likewise, no significant differences were detected between the three groups regarding the presence of fibrosis and inflammation (p>0.05). CONCLUSION Number of ICs, neurons, presence of fibrosis and inflammation seem to be similar in the intact UPJ and UPJ with obstruction with and without crossing vessel. Cellular function rather than the number ICs might play a role that warrants further research.

[1]  S. Gurocak,et al.  Changes in Cajal cell density in ureteropelvic junction obstruction in children. , 2016, Journal of pediatric urology.

[2]  M. Leclair,et al.  Long-term results with the laparoscopic transposition of renal lower pole crossing vessels. , 2015, Journal of pediatric urology.

[3]  A. Gedik,et al.  Does the histopathologic pattern of the ureteropelvic junction affect the outcome of pyeloplasty. , 2015, Urology journal.

[4]  N. Rakhshani,et al.  Changes in Structure, Interstitial Cajal-like Cells and Apoptosis of Smooth Muscle Cells in Congenital Ureteropelvic Junction Obstruction , 2014, Iranian journal of pediatrics.

[5]  W. Apoznański,et al.  The distribution of interstitial cells of Cajal in congenital ureteropelvic junction obstruction , 2013, International Urology and Nephrology.

[6]  W. Apoznański,et al.  Changes in interstitial cell of Cajal-like cells density in congenital ureteropelvic junction obstruction , 2011, International Urology and Nephrology.

[7]  A. Kazez,et al.  The roles of extracellular matrix proteins, apoptosis and c-kit positive cells in the pathogenesis of ureteropelvic junction obstruction. , 2010, Journal of pediatric urology.

[8]  S. Payabvash,et al.  Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction. , 2006, The Journal of urology.

[9]  H. Dietz,et al.  Cajal-like cells in the upper urinary tract: comparative study in various species , 2005, Pediatric Surgery International.

[10]  H. Dietz,et al.  Cajal-like cells in the human upper urinary tract. , 2004, The Journal of urology.

[11]  P. Puri,et al.  Altered expression of interstitial cells of Cajal in congenital ureteropelvic junction obstruction. , 2003, The Journal of urology.

[12]  H. Choi,et al.  Collagen-to-smooth muscle ratio helps prediction of prognosis after pyeloplasty. , 2000, The Journal of urology.

[13]  T. Ushiki,et al.  Structural changes of collagen components and diminution of nerves in congenital ureteropelvic junction obstruction. , 1997, The Journal of urology.

[14]  D. Reen,et al.  Abnormal innervation and altered nerve growth factor messenger ribonucleic acid expression in ureteropelvic junction obstruction. , 1995, The Journal of urology.

[15]  S. Nishikawa,et al.  Requirement of c-kit for development of intestinal pacemaker system. , 1992, Development.